This is a meaningful biological effect, but it operates at a different scale and duration than pharmaceutical GLP-1 agonists
Yet only 25% of employers cover GLP-1s today, according to a recent survey by care delivery and navigation company Accolade
Reddys Eris Lifesciences Emcure Pharmaceuticals Glenmark Pharmaceuticals Lupin MSN Natco Pharma Novo Nordisk Sun Pharma Torrent Pharmaceuticals USV Zydus In addition, more than 20 companies have sourced semaglutide API in the past 12 months, suggesting a second wave of entrants that are either delayed or taking a wait-and-see approach amid downward pricing pressure (Figure 1)
The SURMOUNT-1 trial (tirzepatide, published in NEJM 2022) demonstrated that participants with obesity or overweight without diabetes who received tirzepatide experienced weight reductions of 16.0% (5mg), 21.4% (10mg), and 22.5% (15mg) over 72 weeks
Not because the surgery was done wrong
No matter which you chooseor if you decide to try bothlisten to your body and consult with a healthcare provider to find the best fit for your unique needs